Abstract
Since the declaration of coronavirus disease 2019 (COVID-19) pandemic, patients with migraine were specifically vulnerable to worsening of their headaches. Traditional medicine (TM) has been used to treat headache disorders for centuries, especially during times of a healthcare emergencies, similar to the current pandemic. We aimed to assess the use of TM in treatment of migraine amid COVID-19 pandemic in Kuwait, using an online, self-administered questionnaire. A total of 1018 patients completed the survey. TM was used by 39.9% respondents. The greatest users of TM were those with older age (p =0.04), and longer disease duration (p =0.005). TM users were found to be more compliant to treatments than non-TM users (p<0.02). However, they reported significantly less communication with their physicians (p <0.001) during the pandemic. This study showed higher rates of TM use, as a way of self-treatment, among patients with migraine during COVID-19 pandemic. Neurologists should prepare their patients with “rescue” strategies for headache management, and new means of communication, to face these “new normal” challenges.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received no funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Scientific Research Committee of Department of Neurology, Ibn Sina hospital, Kuwait, the dedicated ethics oversight body, in July 2020. Answering the survey was considered an implied consent to participate in the study, as approved by the Scientific Research Committee of the department, based on the fact that completing the survey was voluntary, and all answers were confidential.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- COVID-19
- Coronavirus disease 2019
- TM
- Traditional medicine
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.